| DG172 (dihydrochloride) |
1361504-77-9 |
1361504-77-9 |
| MSA-2 |
MSA-2 |
129425-81-6 |
| EGFR-IN-7 (compound 34) |
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 |
2267329-76-8 |
| PHA-767491 (hydrochloride) |
1,5,6,7-四氢-2-(4-吡啶基)-4H-吡咯并[3,2-C]吡啶-4-酮盐酸盐 |
942425-68-5 |
| exo-IWR 1 |
exo-IWR 1 |
1127442-87-8 |
| NS 3623 |
NS 3623 |
343630-41-1 |
| 8-Epidiosbulbin E acetate |
8-Epidiosbulbin E acetate |
91095-48-6 |
| YU238259 |
YU238259 |
1943733-16-1 |
| MLS-573151 |
MLS-573151 |
10179-57-4 |
| SJB2-043 |
SJB2-043 |
63388-44-3 |
| FGFR inhibitor |
SSR128129E |
848318-25-2 |
| Psoralenoside |
补骨脂苷 |
905954-17-8 |
| Ripasudil hydrochloride dihydrate |
(2S)-1-[(4-氟-5-异喹啉基)磺酰基]六氢-2-甲基-1H-1,4-二氮杂卓单盐酸盐二水合物 |
887375-67-9 |
| GSK2656157 |
GSK2656157 |
1337532-29-2 |
| STF 31 |
4-((4-(叔丁基)苯基磺酰胺基)甲基)-N-(吡啶-3-基)苯甲酰胺 |
724741-75-7 |
| (2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride |
(2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 |
1448189-80-7 |
| Leukadherin 1 |
4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸 |
344897-95-6 |
| SR-18292 |
2095432-55-4 |
2095432-55-4 |
| RSL3 |
CS-2409 |
1219810-16-8 |
| cangrelor tetrasodium |
坎格雷洛四钠盐 |
163706-36-3 |
QQ
微信
